HCID 178472562, compound → HCID 178525819, compound
Reaction equation
C([O:3][C:4](=[O:39])[C@@H:5]([NH:15][C@H:16]([C:31](=[O:38])[NH:32][C:33]1[NH:37][N:36]=[N:35][N:34]=1)[CH2:17][C:18]1[CH:23]=[CH:22][C:21]([C:24]2[CH:29]=[CH:28][CH:27]=[C:26]([Cl:30])[CH:25]=2)=[CH:20][CH:19]=1)[CH2:6][O:7]CC1C=CC=CC=1)C>CCOC(C)=O.CCO.[Pd]>[Cl:30][C:26]1[CH:25]=[C:24]([C:21]2[CH:20]=[CH:19][C:18]([CH2:17][C@H:16]([NH:15][C@@H:5]([CH2:6][OH:7])[C:4]([OH:39])=[O:3])[C:31](=[O:38])[NH:32][C:33]3[NH:37][N:36]=[N:35][N:34]=3)=[CH:23][CH:22]=2)[CH:29]=[CH:28][CH:27]=1Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 50 °C
Procedure
To a solution of (S)-3-benzyloxy-2-[(S)-2-(3′-chloro-biphenyl-4-yl)-1-(1H-tetrazol-5-ylcarbamoyl)-ethylamino]-propionic acid ethyl ester (Example 32-8: 47 mg, 0.090 mmol) in EtOAc (1 mL) and EtOH (1 mL) was added 5% Pd—C (9.6 mg, 0.0045 mmol). H2 gas was loaded with a balloon and the reaction mixture was stirred at 50° C. for 6 hours. The reaction mixture was filtered through celite pad and the filtrate was concentrated. The residue was purified by reverse phase HPLC (Sunfire C-18 column, eluent: 0.1% TFA in H2O/CH3CN) to give (S)-2-[(S)-2-(3′-chloro-biphenyl-4-yl)-1-(1H-tetrazol-5-ylcarbamoyl)-ethylamino]-3-hydroxy-propionic acid and (S)-2-[(S)-2-biphenyl-4-yl-1-(1H-tetrazol-5-ylcarbamoyl): ethylamino]-3-hydroxy-propionic acid.
Workup
- filtrationThe reaction mixture was filtered through celite pad
- concentrationthe filtrate was concentrated
- customThe residue was purified by reverse phase HPLC (Sunfire C-18 column, eluent: 0.1% TFA in H2O/CH3CN)
Sources & evidence
- ORD record
- ord-d496856db20c4616b4aa3744bd839130
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08993631B2
Reaction notes
Loading…